Activation of the NF-κB signaling pathway (which is closely correlated with inflammation) has been implicated in the pathogenesis of impaired insulin secretion, insulin resistance, and diabetic vascular complications in T2DM [29,30]. This evidence concerns the gene NFKB1 and Insulin resistance.